Tue. Sep 27th, 2022

Author: krehani

Lichen Planus Pipeline Assessment | Insights into the Current Therapies, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Clinical Trials, and Treatment Outlook | Key Companies – Novartis, Amgen, Kiniksa Pharmaceuticals, AFYX Therapeutics, Regeneus, Actellion

“Lichen Planus Pipeline Insight, 2022” report by DelveInsight outlines a comprehensive assessment of the present clinical/non-clinical development activities and growth…

Charcot-Marie-Tooth Disease Pipeline Assessment, 2022 – Insights Into the Latest FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, and Growth Prospects | Key Companies – Acceleron Pharma, Pharnext, Pharnext, MedDay Pharmaceuticals

“Charcot-Marie-Tooth Disease Pipeline Insight, 2022” report by DelveInsight outlines a comprehensive assessment of the present clinical/non-clinical development activities and growth…

Candidemia Therapeutic Pipeline Analysis | Insights into the Latest FDA, EMA, and PMDA Approvals, Breakthroughs, Clinical and Non-Clinical Trials, Emerging Therapies, and Treatment Algorithm | Key Companies – Cidara Therapeutics, Scynexis, Amplyx Pharmaceuticals

As per DelveInsight’s assessment, globally, about 4+ key pharma and biotech companies are working on 4+ pipeline drugs in the…

Hunter Syndrome Pipeline Insights, 2022 : Comprehensive Assessment into the Ongoing Clinical Trials, Treatment Algorithm, Novel and Emerging Therapies | Key Companies – JCR Pharmaceuticals, Takeda, GC Pharma, Denali Therapeutics, Regenxbio, Sanagamo, AVROBIO, Capsida, GENERIUM, ArmaGen, Homology Medicines

“Hunter Syndrome Pipeline Insight, 2022” report by DelveInsight outlines a comprehensive assessment of the present clinical/non-clinical development activities and growth…

Ichthyosis Therapeutic Pipeline Analysis | Insights into the Latest FDA, EMA, and PMDA Approvals, Clinical and Non-Clinical Trials, Emerging Therapies, and Treatment Algorithm | Mayne Pharma, Galderma, Patagonia Pharmaceuticals, Crown Laboratories, Timber Pharmaceuticals

“Ichthyosis Pipeline Insight, 2022” report by DelveInsight outlines a comprehensive assessment of the present clinical/non-clinical development activities and growth prospects…